Core Laboratories/$CLB
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Core Laboratories
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
- Ticker
- $CLB
- Sector
- Energy
- Primary listing
- NYSE
- Employees
- 3,300
- Headquarters
- Houston, United States
- Website
- www.corelab.com
CLB Metrics
BasicAdvanced
$488M
31.49
$0.34
1.14
$0.04
0.38%
Price and volume
Market cap
$488M
Beta
1.14
52-week high
$20.36
52-week low
$9.13
Average daily volume
710K
Dividend rate
$0.04
Financial strength
Current ratio
2.191
Quick ratio
1.333
Long term debt to equity
0.529
Total debt to equity
0.57
Dividend payout ratio (TTM)
11.86%
Interest coverage (TTM)
3.07%
Profitability
EBITDA (TTM)
49.169
Gross margin (TTM)
19.10%
Net profit margin (TTM)
3.01%
Operating margin (TTM)
6.62%
Effective tax rate (TTM)
43.76%
Revenue per employee (TTM)
$160,000
Management effectiveness
Return on assets (TTM)
3.61%
Return on equity (TTM)
5.57%
Valuation
Price to earnings (TTM)
31.494
Price to revenue (TTM)
0.948
Price to book
1.75
Price to tangible book (TTM)
7.35
Price to free cash flow (TTM)
75.201
Free cash flow yield (TTM)
1.33%
Free cash flow per share (TTM)
0.141
Dividend yield (TTM)
0.38%
Forward dividend yield
0.38%
Growth
Revenue change (TTM)
-0.15%
Earnings per share change (TTM)
-50.31%
3-year revenue growth (CAGR)
0.49%
10-year revenue growth (CAGR)
-1.93%
3-year earnings per share growth (CAGR)
-27.42%
10-year earnings per share growth (CAGR)
-13.71%
10-year dividend per share growth (CAGR)
-33.02%
What the Analysts think about CLB
Analyst ratings (Buy, Hold, Sell) for Core Laboratories stock.
Analyst projections of the future price of Core Laboratories stock.
Bulls say / Bears say
The near-term trend is improving: Q2 revenue rose 2.3% sequentially, and management forecast Q3 revenue of $128.5 million to $135.5 million, citing better activity in Africa, the US and Asia-Pacific. (PR Newswire)
Production Enhancement is a growth driver: Q2 revenue rose 15% sequentially and 5% year on year to $45.9 million, as sales of completion products and diagnostic services improved and operators adopted more of its technologies. (PR Newswire)
Core Lab has won technical work on exploration, appraisal and carbon-storage projects in Asia-Pacific and Africa, including an Australian gas development. These engagements broaden its project pipeline beyond established producing fields. (PR Newswire)
Geopolitical disruption remains a direct earnings drag: Q2 Reservoir Description revenue fell 9% year on year to $78.7 million and its operating margin was 5%. Management expected conflict-related delays and logistical constraints to continue into Q3. (PR Newswire)
Profit remains below last year’s level: Q2 revenue fell 4.3% year on year and adjusted EPS declined to $0.11 from $0.19, with higher costs adding pressure. (Yahoo Finance)
Cash generation has weakened: first-half operating cash fell to $11.8 million from $20.6 million a year earlier, while capital spending rose and inventory absorbed cash. That leaves less financial flexibility if the recovery is delayed. (Yahoo Finance)
Data summarised monthly by Lightyear AI. Last updated on 17 Oct 2026.
CLB Financial Performance
Revenues and expenses
CLB Earnings Performance
Company profitability
Upcoming events
CLB News
AllArticlesVideos
Funds containing CLB
Fund name | Fund size | $CLB weighting |
|---|---|---|
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | $3.2B | 0.02% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | $3.2B | 0.02% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.02% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.02% |
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.